linoleic-acid and propionic-acid

The objective of this trial was to investigate the effects of feeding a soybean oil refining by-product (SORB), made up mainly of sodium salts of long-chain fatty acids, on reproductive performance and productivity of 36 early lactation Holstein cows managed in a free-stall barn or on annual rye-ryegrass pasture. In this 2 x 2 factorial arrangement of treatments, cows consumed 0 or 0.5 kg/d of SORB as part of a total mixed ration for barn cows or as part of a grain supplement fed to cows on intensively, rotationally stocked pasture. Blood was sampled 3 times weekly and plasma was measured for progesterone to assess ovarian activity. Estrus activity was recorded using the HeatWatch estrus detection system. Although average 14-wk milk production (37.2 kg/d) was not different among treatments, barn cows had more persistent lactations than did grazing cows. Cows housed in the barn lost less body weight and returned to initial body weight sooner and had lower mean concentrations of plasma nonesterified fatty acids (464 vs. 261 mEq/L) than those managed on pasture. The milk fat of cows on pasture contained greater proportions of conjugated linoleic acid and linolenic acid but a corresponding 0.22 percentage unit decrease in milk fat concentration (3.39 vs. 3.16%). Cows managed on pasture had greater peak concentrations of plasma progesterone during the first estrous cycle. Cows managed on pasture and fed SORB had the greatest accumulation of plasma progesterone over the 14 wk of the study (SORB x housing interaction). These cows experienced the most mounts during their first estrus (9.3) and pregnancy rate was also greatest for this treatment (62.5%). Feeding SORB did not affect production of milk, fat, or protein. Loss of body condition was less in cows fed SORB. Ruminal fluid concentration of propionate increased and ruminal pH decreased in cows fed SORB. A lower proportion of fatty acids less than 18 carbons in length was found in the milk fat of cows fed SORB, thus indicating lower de novo synthesis of fatty acids. Higher proportions of C18:2n-6 and conjugated C18:2 were found in the milk fat of cows fed SORB. Based on concentrations of plasma progesterone, cows fed SORB experienced their first ovulation earlier (26.7 vs. 42.4 d postpartum) than did cows not supplemented with SORB. Neither housing system nor SORB supplementation influenced detection of first estrus (50.5 d) or the mean length of each estrus period (447 min).

Topics: alpha-Linolenic Acid; Animals; Body Composition; Body Weight; Cattle; Diet; Dietary Fats; Edible Grain; Estrus; Estrus Detection; Fats; Fatty Acids, Volatile; Female; Hydrogen-Ion Concentration; Lactation; Linoleic Acid; Milk; Milk Proteins; Pregnancy; Progesterone; Propionates; Reproduction; Rumen; Soybean Oil

Fatty acids are critical for pediatric neurodevelopment and are abnormal in autism, although prior studies have demonstrated conflicting results and methodological differences. To our knowledge, there are no published data on fatty acid in Canadian children with autism. The aim of this study was to investigate red blood cell and serum fatty acid status to identify whether abnormalities exist in Canadian children with autism, and to enhance future cross-study comparison.. Eleven Canadian children with autism (3 girls, 8 boys; age 3.05 ± 0.79 y) and 15 controls (9 girls, 6 boys; age 3.87 ± 1.06 y) met inclusion criteria, which included prior Diagnostic and Statistical Manual diagnosis of autism spectrum disorder, no recent medication or supplements, no specialty diets, and no recent illness.. The children with autism demonstrated lower red blood cell docosahexaenoic acid (P < 0.0003), eicosapentaenoic acid (P < 0.03), arachidonic acid (P < 0.002), and ω-3/ω-6 ratios (P < 0.001). They also demonstrated lower serum docosahexaenoic acid (P < 0.02), arachidonic acid (P < 0.05), and linoleic acid (P < 0.02) levels.. Fatty acids in both serum and red blood cells were abnormal in this small group of Canadian children with autism than in controls, underlining a need for larger age- and sex-matched investigations in this community. A potential role for fatty acid abnormalities within the complex epigenetic etiology of autism is proposed in relation to emerging understanding of relationships between cobalamin metabolism, gut microbiota, and propionic acid production.

Topics: Arachidonic Acid; Autism Spectrum Disorder; Autistic Disorder; Canada; Case-Control Studies; Child, Preschool; Cross-Sectional Studies; Docosahexaenoic Acids; Eicosapentaenoic Acid; Erythrocytes; Fatty Acids; Fatty Acids, Omega-6; Female; Humans; Linoleic Acid; Male; Propionates; Vitamin B 12

The objectives were to determine the long-term (48 h) effects of specific long chain fatty acids on hepatic lipid and glucose metabolism in monolayer cultures of bovine hepatocytes. From 16 to 64 h after plating, hepatocytes from three 7- to 10-d-old calves were exposed to one of the following treatments: 1 mM palmitic acid (1 mM C16:0), 2 mM palmitic acid (2 mM C16:0), or 1 mM palmitic acid plus 1 mM of either stearic (C18:0), oleic (C18:1), linoleic (C18:2), linolenic (C18:3), eicosapentaenoic (C20:5), or docosahexaenoic (C22:6) acid, or 0.5 mM each of eicosapentaenoic and docosahexaenoic acid (C20:5 + C22:6). The two treatments containing 2 mM of saturated fatty acids, 2 mM C16:0 and 1 mM C16:0 plus 1 mM C18:0, increased beta-hydroxybutyrate concentrations in the medium and [1-(14)C]palmitic acid oxidation to acid-soluble products compared with all other treatments. The treatment containing C22:6 increased total cellular triglyceride content and incorporation of [1-(14)C]palmitic acid into cellular triglycerides. The treatments containing C22:6 or C20:5 + C22:6 increased [1-(14)C]palmitic acid metabolism to phospholipids and cholesterol. The presence of C22:6 in the medium decreased metabolism of [2-(14)C]propionic acid either to glucose in the medium or to cellular glycogen. Overall, fatty acids differed in their effects on lipid and glucose metabolism in monolayer cultures of bovine hepatocytes with C22:6 eliciting the most profound changes.

Topics: 3-Hydroxybutyric Acid; alpha-Linolenic Acid; Animals; Carbon Radioisotopes; Cattle; Cells, Cultured; Cholesterol; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids; Gluconeogenesis; Glucose; Glycogen; Hepatocytes; Linoleic Acid; Lipid Metabolism; Male; Oxidation-Reduction; Palmitic Acid; Phospholipids; Propionates; Stearic Acids; Triglycerides

The objectives were to determine the metabolic fate of different long-chain fatty acids, and their effects on palmitic acid metabolism and gluconeogenesis in bovine hepatocytes. Hepatocytes were isolated from four ruminating calves and exposed in suspension for 3 h to one of the following treatments: 1 mM palmitic acid (1C16), 2 mM palmitic acid (2C16), or 1 mM palmitic acid plus either 1 mM oleic (C18:1), linoleic (C18:2), linolenic (C18:3), eicosapentaenoic (C20:5), or docosahexaenoic acid (C22:6). Oxidation of [1-(14)C]palmitic acid or one of the [1-(14)C]-labeled treatment fatty acids to CO2 or incorporation into cellular triglycerides (TG), phospholipids, cholesterol, and cholesterol esters were measured. Rates of oxidation to CO2 were 3- to 4-fold higher for C22:6 than for other fatty acids, with the exception of C20:5, which had intermediate rates of oxidation to CO2. In general, treatments 2C16 and C18:1 yielded the highest rates of incorporation into most cellular lipids, whereas the polyunsaturated fatty acids were poor substrates for incorporation into cellular lipids. The most pronounced change was a large reduction of polyunsaturated fatty acid incorporation into cellular TG compared to 1C16, 2C16, and C18:1. The unsaturated fatty acids also influenced palmitic acid metabolism. The addition of C20:5 yielded the highest rates of palmitic acid oxidation to CO2 followed by addition of C18:1 and C22:6. Treatments containing polyunsaturated fatty acids decreased palmitic acid metabolism to TG and total cellular lipids compared with treatments 2C16 and C18:1. Rates of gluconeogenesis from propionate were significantly higher for the treatment containing C18:1. Long-chain fatty acids vary in their routes of metabolism and influence palmitic acid metabolism and gluconeogenesis in bovine hepatocytes.

Topics: alpha-Linolenic Acid; Animals; Cattle; Cells, Cultured; Cholesterol; Cholesterol Esters; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Gluconeogenesis; Hepatocytes; Linoleic Acid; Male; Oleic Acid; Oxidation-Reduction; Palmitic Acid; Phospholipids; Propionates; Triglycerides